What is Abbott Laboratories's Market Cap?

Abbott Laboratories's Market Cap is $187.5B, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's Enterprise Value?

Abbott Laboratories's Enterprise Value is $214.5B, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's Trailing P/E?

Abbott Laboratories's Trailing P/E is 34.6×, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's Price / Sales?

Abbott Laboratories's Price / Sales is 4.0×, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's EV / Revenue?

Abbott Laboratories's EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's EV / EBITDA?

Abbott Laboratories's EV / EBITDA is 19.9×, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's Revenue (TTM)?

Abbott Laboratories's Revenue (TTM) is $46.6B, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's Net Income (TTM)?

Abbott Laboratories's Net Income (TTM) is $5.4B, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's EBITDA?

Abbott Laboratories's EBITDA is $10.8B, based on as-reported figures from SEC (XBRL) filings.

What is Abbott Laboratories's Diluted EPS (TTM)?

Abbott Laboratories's Diluted EPS (TTM) is 3.14, based on as-reported figures from SEC (XBRL) filings.

Abbott Laboratories (ABT) Financial Statements

Abbott Laboratories

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001S5N9M6

XNYS · usd

108.33▼ 0.46 (-0.42%)

As of 2026-09-04

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close108.79

Day's Range107.36 – 110.01

52-Week Range81.97 – 137.49

Volume6.9M

Avg Volume7.7M

Share Statistics

Shares Outstanding

Employees115.0K

ExchangeXNYS

Listed1949-04-19

Share count as of June 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Abbott Laboratories (ABT)

What is Abbott Laboratories's Market Cap?: Abbott Laboratories's Market Cap is $187.5B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Enterprise Value?: Abbott Laboratories's Enterprise Value is $214.5B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Trailing P/E?: Abbott Laboratories's Trailing P/E is 34.6×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Price / Sales?: Abbott Laboratories's Price / Sales is 4.0×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's EV / Revenue?: Abbott Laboratories's EV / Revenue is 4.6×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's EV / EBITDA?: Abbott Laboratories's EV / EBITDA is 19.9×, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Revenue (TTM)?: Abbott Laboratories's Revenue (TTM) is $46.6B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Net Income (TTM)?: Abbott Laboratories's Net Income (TTM) is $5.4B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's EBITDA?: Abbott Laboratories's EBITDA is $10.8B, based on as-reported figures from SEC (XBRL) filings.
What is Abbott Laboratories's Diluted EPS (TTM)?: Abbott Laboratories's Diluted EPS (TTM) is 3.14, based on as-reported figures from SEC (XBRL) filings.